Search results for "urinary bladder"

showing 7 items of 327 documents

Cigarette Smoking and Drinking Water Source: Correlation with Clinical Features and Pathology of Superficial Bladder Carcinoma

2007

<i>Objective:</i> Water source and cigarette smoking are related to clinical characteristics and pathology of superficial transitional cell carcinoma of the bladder. <i>Methods:</i> Tumor number, dimension, G-grade, T-stage, recurrences, cigarette smoking and water supply were recorded in patients harboring Ta–T1 G1–3 transitional cell carcinoma of the bladder. <i>Results:</i> Of 577 patients, 61% had multiple and 36% recurrent tumors. Two hundred and forty-one patients (42%) were current smokers and 188 (33%) were former smokers. Bottled water was the only drinkable source for 249 (45%) patients, municipal water supply for 177 (32%), artesian wells for 3…

AdultMalePathologymedicine.medical_specialtyUrologyWater sourceRisk AssessmentCigarette smokingRecurrenceRisk FactorsWater SupplyOdds RatioCarcinomaHumansMedicineWater PollutantsAgedNeoplasm StagingAged 80 and overCarcinoma Transitional CellBladder cancerbusiness.industrySmokingdigestive oral and skin physiologyOdds ratioMiddle Agedmedicine.diseaseTransitional cell carcinomaItalyUrinary Bladder NeoplasmsMultivariate AnalysisFemaleNeoplasm stagingSuperficial Bladder CarcinomabusinessUrologia Internationalis
researchProduct

Strategies for reconstruction after unsuccessful or unsatisfactory primary treatment of patients with bladder exstrophy or incontinent epispadias.

1999

Following unsuccessful or unsatisfactory primary treatment in patients with the epispadias/exstrophy complex, the options for a surgical solution to preserve the upper urinary tract, to achieve complete continence, and to reconstruct the external and female internal genitalia are limited. We reviewed the records of the patients treated at our institution to determine a surgical compromise between ingenious operative constructions and patient desires, both of which are secondary to stabilization of renal function.From 1967 to December 1997, 128 patients with bladder exstrophy/epispadias complex were treated, of 80 whom had received previous unsuccessful or unsatisfactory treatment. Of these …

AdultMaleReoperationmedicine.medical_specialtyEpispadiasUrologymedicine.medical_treatmentUrinary incontinenceEpispadiasUrologic Surgical ProcedureUreterosigmoidostomymedicineHumansTreatment FailureChildUrinary bladderbusiness.industryBladder ExstrophyInfantmedicine.diseaseSurgeryBladder exstrophyPlastic surgeryNeck of urinary bladdermedicine.anatomical_structureUrinary IncontinenceChild PreschoolUrologic Surgical ProceduresFemalemedicine.symptombusinessFollow-Up StudiesThe Journal of urology
researchProduct

Does Smoking Cessation at Primary Diagnosis Reduce the Recurrence Risk of Nonmuscle-Invasive Bladder Cancer? Results of a Prospective Study.

2020

<b><i>Introduction:</i></b> Evidence that smoking cessation at first diagnosis of nonmuscle-invasive bladder cancer (NMIBC) reduces the risk of recurrence is lacking. The aim of our prospective study was to analyze the association between patients’ changes in smoking habits after diagnosis and recurrence-free survival (RFS). <b><i>Patients:</i></b> After transurethral resection of primary NMIBC, patients were classified as “ex-smokers,” i.e., those definitively stopping, and as “active smokers,” i.e., those continuing or restarting to smoke. Smoking status was reassessed every 3 months during the first year and every 6 months thereafter. Data …

medicine.medical_specialtyMultivariate analysisUrologymedicine.medical_treatmentDisease-Free SurvivalRecurrence riskCigarette smokingRecurrenceInternal medicinemedicineNonmuscle-invasive bladder cancerHumansStatistical analysisNeoplasm InvasivenessProspective StudiesProspective cohort studyPathologicalAgedBladder cancerbusiness.industryMiddle Agedmedicine.diseasePrimary tumorUrinary Bladder NeoplasmsSmoking cessationSmoking CessationNeoplasm Recurrence LocalbusinessUrologia internationalis
researchProduct

Radical Cystectomy - Often Too Late?

1987

From 1967 to 1985, 246 cystectomies for treatment of transitional cell carcinoma of the urinary bladder were performed. Perioperative mortality decreased from 15% in the early years to 0% in 1985. Preoperative radiotherapy was not given. Patients who underwent cystectomy immediately following the diagnosis of invasive bladder carcinoma had a significantly better prognosis than those having cystectomy after recurrence of a transurethrally resected invasive carcinoma in spite of identical G and T criteria. A total of 26 patients who were cystectomized because of tumor recurrence after definitive radiotherapy (salvage cystectomy) represented the group with the worst prognosis: they had a 5-yea…

medicine.medical_specialtyTime FactorsUrologymedicine.medical_treatmentUrologyCystectomyMethodsCarcinomamedicineAdjuvant therapyHumansSurvival rateCarcinoma Transitional CellUrinary bladderBladder cancerbusiness.industryPerioperativeMiddle AgedPrognosismedicine.diseaseSurgerymedicine.anatomical_structureTransitional cell carcinomaUrinary Bladder NeoplasmsNeoplasm Recurrence LocalbusinessEuropean Urology
researchProduct

Increased blood flow after catheterization and drainage in the chronically obstructed rabbit urinary bladder

2001

Abstract Objectives. To determine the effect of drainage on rabbit bladder blood flow after 4 weeks of partial outlet obstruction. Previous studies have shown that catheterization and drainage of the urinary bladder in control rabbits resulted in a significant nitric oxide-induced increase of blood flow to the bladder. It was also shown that 4 weeks’ partial outlet obstruction caused a significant decrease in blood flow to the bladder. Methods. Male New Zealand White rabbits underwent partial outlet obstruction by standard methods. After 4 weeks, the blood flow to the bladder muscle and mucosa was determined by a microsphere technique. Within 1 to 2 minutes after transurethral catheterizati…

Malemedicine.medical_specialtyUrologyUrinary systemmedicine.medical_treatmentUrinary BladderUrologyUrineAbdominal fasciaUrineurologic and male genital diseasesUrinary catheterizationPressuremedicineAnimalsDrainageMucous MembraneUrinary bladderLagomorphabiologybusiness.industryMuscle SmoothOrgan SizeBlood flowbiology.organism_classificationSurgeryUrinary Bladder Neck Obstructionmedicine.anatomical_structureRegional Blood FlowChronic DiseaseDrainageRabbitsUrinary CatheterizationbusinessUrology
researchProduct

Immunohistochemical expression of Ki-67, Cyclin D1, p16INK4a, and Survivin as a predictive tool for recurrence and progression-free survival in papil…

2019

Objectives: To investigate the expression of several immunohistochemical (IHC) markers and their predictive ability for the recurrence-free and progression-free survival of papillary urothelial bladder cancer (UBC) pTa/pT1 G2 (WHO 1973) compared to classical anatomo-clinical variables using a multidimensional analysis. Materials and Methods: A population-based cohort of 213 primary stage UBC (pTa/pT1) G2 (WHO 1973) was evaluated by classic anatomopathological variables and characterized by immunohistochemistry (23 IHC markers, representative of different oncogenic pathways). The most important variables as a predictor of recurrence-free and progression-free survival were selected using mult…

MaleOncologymedicine.medical_specialtyMultidimensional analysisSurvivinUrologyPopulation030232 urology & nephrologyCohort Studies03 medical and health sciences0302 clinical medicineCyclin D1Stage Ta/T1Predictive Value of TestsInternal medicineSurvivinBiomarkers TumormedicineHumansCyclin D1Progression-free survivalStage (cooking)educationCyclin-Dependent Kinase Inhibitor p16AgedNeoplasm Stagingeducation.field_of_studyBladder cancerbiologybusiness.industryClinical outcomeBladder cancerMiddle Agedmedicine.diseaseImmunohistochemistryCarcinoma PapillarySurvival RateKi-67 AntigenUrinary Bladder NeoplasmsOncology030220 oncology & carcinogenesisKi-67biology.proteinImmunohistochemistryFemaleNeoplasm GradingNeoplasm Recurrence LocalbusinessFollow-Up Studies
researchProduct

Prognostic Value of p53, p21/WAF1, Bcl-2, Bax, Bak and Ki-67 Immunoreactivity in pT1 G3 Urothelial Bladder Carcinomas

2001

pT1 G3 bladder carcinomas are heterogeneous with respect to tumor recurrence and progression. Whereas some urologists treat these carcinomas by repeated transurethral resections often followed by intravesical chemotherapy or BCG instillation, others recommend cystectomy after tumor recurrence or early cystectomy after the initial diagnosis. Our goal was to determine the prognostic value of p53, p21/WAF1, Bcl-2, Bax, Bak, and Ki-67 immunoreactivity in these tumors. There were 30 patients with a new histopathological diagnosis of pT1 G3 urothelial carcinoma based on a transurethral resection specimen. Representative sections of these specimens were examined for the above markers. All patients…

Cyclin-Dependent Kinase Inhibitor p21medicine.medical_specialtyPathologyTime FactorsTumor suppressor genemedicine.medical_treatmentBcl 2 baxUrologyDisease-Free SurvivalCystectomyPredictive Value of TestsCyclinsProto-Oncogene ProteinsBiomarkers TumormedicineHumansNeoplasm InvasivenessRetrospective Studiesbcl-2-Associated X ProteinCarcinoma Transitional CellUrinary bladderBladder cancerbiologyMembrane ProteinsGeneral MedicinePrognosismedicine.diseaseImmunohistochemistrySurvival RateKi-67 Antigenbcl-2 Homologous Antagonist-Killer Proteinmedicine.anatomical_structureTransitional cell carcinomaProto-Oncogene Proteins c-bcl-2Urinary Bladder NeoplasmsTumor progressionKi-67biology.proteinTumor Suppressor Protein p53Follow-Up StudiesTumor Biology
researchProduct